Rainflower Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 122.09%
- Profit Growth 100.90%
- Ebitda 102.97%
- Net Worth 19.37%
- Total Assets 43.79%
About Rainflower Pharmaceuticals
Rainflower Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2013 and has a history of 11 years and three months. Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Jagirbhai Parsaniya, Kishan Trambadiya, Parag Bhatt, and One other member serve as directors at the Company.
Company Details
-
Location
Rajkot, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2013PTC077249
-
Company No.
077249
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Rainflower Pharmaceuticals Private Limited offer?
Rainflower Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Metformin Tablets, Metformin & Vildagliptin Tablet, Antacid Drugs, Rabeprazole Domperidone Capsule, Diabetes Medicine, Pioglitazone Hydrochloride Tablet, Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet.
Who are the key members and board of directors at Rainflower Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagirbhai Parsaniya
|
Director | 30-Jun-2022 | Current |
|
Kishan Trambadiya
|
Director | 30-Jun-2022 | Current |
|
Parag Bhatt
|
Director | 30-Jun-2022 | Current |
|
Mansukhlal Jethva
|
Director | 30-Jun-2022 | Current |
Financial Performance of Rainflower Pharmaceuticals.
Rainflower Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.09% increase. The company also saw a substantial improvement in profitability, with a 100.9% increase in profit. The company's net worth Soared by an impressive increase of 19.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rainflower Pharmaceuticals?
Unlock access to Rainflower Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2024 | Others | ₹1.00 M | Open |
How Many Employees Work at Rainflower Pharmaceuticals?
Unlock and access historical data on people associated with Rainflower Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rainflower Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rainflower Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
